US seniors set to reap benefits?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.350, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aluminium in Over-the-Counter Drugs: Risks Outweigh Benefits?

By Reinke C.M.

Drug Safety, Vol. 26, Iss. 14, 2003-01 ,pp. : 1011-1025

Adis International

Access to resources Recommend Favorite

Risk of Melanoma with Psoralen/Ultraviolet A Therapy for Psoriasis: Do the Known Risks Now Outweigh the Benefits?

By Lindelöf B.

Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. : 289-297

Adis International

Access to resources Recommend Favorite

Tocopherol: cardiovascular benefits in haemodialysis?

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The return of Tysabri to the market in the US?

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Screening for proteinuria warranted in the US?

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite